• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Essex Woodlands Health Ventures

edit

Essex Woodlands was founded in 1985 with the establishment of Essex Venture Fund I, LP. Since 1985, the Partnership has raised seven additional funds with nearly $2.5 billion under management, making Essex Woodlands one of the world’s largest and most established healthcare venture capital firms. The team is comprised of 23 professionals with principal offices in Palo Alto, Houston, New York and London. This team brings over 300 years of collective healthcare experience.

For over 20 years, the firm has maintained its dedicated focus to diversified healthcare investing—primarily serving as lead investor in the founding or the critical financings of over 100 healthcare companies in pharmaceutical, biotechnology, medical device, services and information technology sectors. In addition to its long-standing commitment to early stage companies, the firm has over a decade of experience as a leading late-stage healthcare investor, which includes mature venture, growth equity and PIPE investment opportunities.

Recent Milestones

edit

• 
  Essex Woodlands Health Ventures invested in Revance Therapeutics. (4/2/13)
  Posted 4/5/13 at 4:45am via biocentury.com
• 
  Essex Woodlands Health Ventures invested in Kona Medical. (12/4/12)
  Posted 12/5/12 at 12:16am via bizjournals.com
• 
  Essex Woodlands Health Ventures invested in Kona Medical. (5/30/12)
  Posted 5/30/12 at 7:21pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in BreatheAmerica. (9/6/11)
  Posted 9/6/11 at 5:47pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in Entellus Medical. (8/17/11)
  Posted 8/17/11 at 6:15pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in Revance Therapeutics. (6/10/11)
  Posted 6/10/11 at 6:17pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in Symphogen. (2/14/11)
  Posted 2/14/11 at 4:01am via onbiovc.com
• 
  Essex Woodlands Health Ventures invested in Symphogen. (1/6/11)
  Posted 1/6/11 at 6:37pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in Endologix. (10/27/10)
  Posted 10/28/10 at 8:41pm via endologix.com
• 
  Essex Woodlands Health Ventures invested in ProteinSimple. (10/14/10)
  Posted 10/22/10 at 4:00am via xconomy.com
• 
  Essex Woodlands Health Ventures invested in Accumetrics. (9/1/10)
  Posted 9/7/10 at 5:58pm via finsmes.com
• 
  Essex Woodlands Health Ventures invested in Complete Genomics. (8/19/10)
  Posted 8/19/10 at 6:09pm via completegenomics.com
• 
  Essex Woodlands Health Ventures invested in TearScience. (5/6/10)
  Posted 5/6/10 at 8:50pm via onbiovc.com
• 
  Essex Woodlands Health Ventures invested in Accumetrics. (1/21/10)
  Posted 1/22/10 at 4:15am via onbiovc.com
• 
  Essex Woodlands Health Ventures invested in ikaSystems. (1/19/10)
  Posted 1/20/10 at 8:37pm via dowjones.com
• 
  Essex Woodlands Health Ventures invested in Revance Therapeutics. (1/4/10)
  Posted 12/23/09 at 2:49pm via finsmes.com

Investments

Videos

Sources

1. Revance closes $33 million series E (biocentury.com) [edit]
2. Kona Medical raises $10 million in new Series C funding (bizjournals.com) [edit]
3. Kona Medical Raises $30M in Series C Financing (finsmes.com) [edit]
4. BreatheAmerica Closes $22M Series B Equity Financing (finsmes.com) [edit]
5. Entellus Medical Completes $35M Funding Round (finsmes.com) [edit]
6. Revance Therapeutics Closes $45M Financing (finsmes.com) [edit]
7. Symphogen, AS: Series F $135.4M (onbiovc.com) [edit]
8. Symphogen Closes €100M Round of Financing (finsmes.com) [edit]
9. Endologix to Acquire Nellix (investor.endologix.com) [edit]
10. Cell Biosciences Nabs $20M (xconomy.com) [edit]
11. Accumetrics Raises Additional $7M (finsmes.com) [edit]
12. Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing (completegenomics.com) [edit]
13. TearScience, Inc.: Series C $44.5M (onbiovc.com) [edit]
14. Accumetrics, Inc.: Series E $16.6M (onbiovc.com) [edit]
15. Essex Woodlands, Providence Equity Invest $120M In IkaSystems (fis.dowjones.com) [edit]
16. Revance Raises $25M in Series D Financing (finsmes.com) [edit]
17. Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B (fis.dowjones.com) [edit]
18. MorningStar (news.morningstar.com) [edit]
19. Complete Genomics bags $45M round for sequencing (fiercebiotech.com) [edit]
20. Oraya garners $42M in third venture round (fiercebiotech.com) [edit]
21. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
22. Capital Report Index [edit]
23. Symphogen secures € 33 million financing to support clinical development of antibody products (symphogen.com) [edit]
24. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
25. Nellix raises $6.5M for aneurysm grafts (deals.venturebeat.com) [edit]
26. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial (prnewswire.com) [edit]
27. Secretive Oraya raises more funds for eye devices (venturebeat.com) [edit]
28. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures (coriumgroup.com) [edit]
29. Stealthy Oraya raises $4M for medical devices (venturebeat.com) [edit]
30. StrataGent closes $16M round for needle-free injections (venturebeat.com) [edit]
31. Ception Therapeutics Raises $63 Million in Series C Financing (ceptiontx.com) [edit]
32. NeoVista, a co. targeting age-related macular degeneration, raises $41M (deals.venturebeat.com) [edit]
33. CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING (chromatherapeutics.com) [edit]
34. Symphogen gets $25M for clinical trials for bleeding treatment (bulletin.sciencebusiness.net) [edit]
35. LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS (lsoncology.com) [edit]
36. SEC D/A (sec.gov) [edit]